Safety and efficacy of direct oral anticoagulation in patients with and without radiofrequency ablation of non-valvular atrial fibrillation: a multicenter retrospective cohort study

Table 3 Clinical Outcomes of RFA vs. no RFA in NVAF patients taking DOACs after propensity score matching

	No RFA(n=1700)	RFA(n=1700)	OR(95%CI)	P value
Total bleeding, n(%)	185(10.9)	165(9.7)	0.880(0.705-1.099)	0.259
Major Bleeding, n(%)	34(2.0)	10(0.6)	0.290(0.143-0.589)	<0.001
Thrombosis, n(%)	35(2.1)	18(1.1)	0.509(0.287-0.902)	0.019
All-cause death, n(%)	52(3.1)	47(2.8)	0.901(0.604-1.345)	0.610
Composite outcome^a	266(15.6)	224(13.2)	0.818(0.675-0.991)	0.040

NVAF Non-valvular atrial fibrillation, RFA Radiofrequency ablation, OR Odds ratio, 95%CI 95% Confidence interval
^aComposite outcome included all-cause death, thrombosis and total bleeding

ISSN: 1477-9560